Patent ID: 8404707

Claim:
A compound according to general formula (I), or a pharmaceutically acceptable salt, solvate, tautomer, or enantiomer thereof, wherein: each of R 1 , R 2 , R 3 , R 4 , R 6 and R 7 are independently selected from the group consisting of hydrogen, —OH, —SH, —NH 2 , —NO 2 , halogen, tri-C 1-16 -alkylsilyl, and a C 1-16 hydrocarbyl group which optionally includes one or more heteroatoms at any position of said hydrocarbyl group (in the main or side chains), wherein said heteroatoms are selected from the group consisting of O, S, and N and wherein said hydrocarbyl group is unsubstituted or substituted with one or more Z 1 , and wherein R 2 is not a substituted or unsubstituted amine, R 5 is hydrogen, or a C 1-16 hydrocarbyl group which optionally includes one or more heteroatoms at any position of the hydrocarbyl group (in the main or side chains), wherein heteroatoms are selected from the group consisting of O, S, and N and wherein said hydrocarbyl group is unsubstituted or substituted with one or more Z 1 , Z 1 is selected from the group consisting of —OH, —SH, —NH 2 , halogen, —OCF 3 , —NO 2 , and a C 1-16 hydrocarbyl group which optionally includes one or more heteroatoms at any position of the hydrocarbyl group (in the main or side chains), wherein said heteroatoms are selected from the group consisting of O, S, and N, and which compound is not selected from the following compounds: imidazo[1,2-a]pyrrolo[3,2-c]pyridine, ethyl 2-bromoimidazo[1,2-a]pyrrolo[3,2-c]pyridine-8-carboxylate, and ethyl imidazo[1,2-a]pyrrolo[3,2-c]pyridine-8-carboxylate.